Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fructose SCHEMBL28298046 | 1.00 | CYP2C9 (0.52) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL11432055 | 1.00 | CYP2C9 (0.52) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL28155729 | 1.00 | CYP2C9 (0.52) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL10835862 | 1.00 | CYP2C9 (0.52) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL2638706 | 1.00 | CYP2C9 (0.52) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL7162293 | 0.93 | CYP2C9 (0.56) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL27690289 | 0.93 | CYP2C9 (0.56) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL27668222 | 0.93 | CYP2C9 (0.56) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL6244358 | 0.93 | CYP2C9 (0.54) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL9788519 | 0.93 | CYP2C9 (0.54) | CYP2C9TSHRPDE4ALMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1018645-B | METHOD OF PRODUCING DIACETONE SORBOSE | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1992-10-14 | — | — | CN | claimed |
| US-H708-H | SORBOSE; ACETONE; CATALYST OF IODINE, SULFURIC ACID, PERCHLORIC ACID; ZEOLITE DEHYDRATION; CONTINUOUS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-11-07 | — | — | US | claimed |
| CN-87103553-A | Produce the method for diacetone sorbose | — | 1988-03-09 | — | — | CN | claimed |
| US-4414401-A | Process for separating and recovering metal catalysts | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1983-11-08 | — | — | US | claimed |
| JP-63045292-A | — | — | None | — | — | JP | disclosed |
| US-20230056533-A1 | Radial Glia and Astrocyte Differentiation From Human Pluripotent Stem Cells | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2023-02-23 | — | — | US | disclosed |
| EP-4107255-A1 | RADIAL GLIA AND ASTROCYTE DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services (US) | 2022-12-28 | — | — | EP | disclosed |
| US-8383837-B2 | Reaction with a gold catalyst | DSM IP ASSETS B.V. (NL) | 2013-02-26 | — | — | US | disclosed |
| US-20100217017-A1 | NOVEL REACTION WITH A GOLD CATALYST | DSM IP ASSETS B.V. (NL) | 2010-08-26 | — | — | US | disclosed |
| EP-2155650-A2 | NOVEL REACTION WITH A GOLD CATALYST | DSM IP Assets B.V. (NL) | 2010-02-24 | — | — | EP | disclosed |
| WO-2008148549-A2 | NOVEL REACTION WITH A GOLD CATALYST | DSM IP ASSETS B.V. (NL) | 2008-12-11 | — | — | WO | disclosed |
| CN-1966703-A | Process for one-step fermentation production of gulonic acid (VC precursor) from glucose | GE ZHONGLIANG (CN) | 2007-05-23 | — | — | CN | disclosed |
| CN-87103553-A | Produce the method for diacetone sorbose | — | 1988-03-09 | — | — | CN | disclosed |
| CN-87103553-A | Produce the method for diacetone sorbose | — | 1988-03-09 | — | — | CN | disclosed |
| JP-S6345292-A | PRODUCTION OF DIACETONE SORBOSE | TAKEDA CHEM IND LTD | 1988-02-26 | — | — | JP | disclosed |
| EP-0231354-A1 | PRODUCTION OF A VITAMIN C PRECURSOR USING GENETICALLY MODIFIED ORGANISMS. | BIOGEN NV (NL) | 1987-08-12 | — | — | EP | disclosed |
| WO-1987000863-A1 | PRODUCTION OF A VITAMIN C PRECURSOR USING GENETICALLY MODIFIED ORGANISMS | BIOGEN N.V. (AN) | 1987-02-12 | — | — | WO | disclosed |
| EP-0113835-A1 | Method for the purification of diaceton sorbose | MERCK PATENT GmbH (DE) | 1984-07-25 | — | — | EP | disclosed |
| US-4414401-A | Process for separating and recovering metal catalysts | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1983-11-08 | — | — | US | disclosed |
| US-4414401-A | Process for separating and recovering metal catalysts | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1983-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100217017-A1 | NOVEL REACTION WITH A GOLD CATALYST | ADH1C, ADH1A, ADH5 | CYP2C9 981/4885TSHR 1401/4885PDE4A 4210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.